# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-24-054003
Filing Date
2024-06-20
Accepted
2024-06-20 07:01:40
Documents
21
Period of Report
2024-06-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0208142-8k_aldeyra.htm iXBRL | 8-K | 23646
2 | ALDEYRA THERAPEUTICS, INC. PRESS RELEASE DATED JUNE 20, 2024 | ea020814201ex99-1_aldeyra.htm | EX-99.1 | 28111
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 3779
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 479647
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 517838
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 534511
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 620865
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 632230
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 530777
| Complete submission text file | 0001213900-24-054003.txt |  | 4799407

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL SCHEMA FILE | aldx-20240620.xsd | EX-101.SCH | 3012
11 | XBRL LABEL FILE | aldx-20240620_lab.xml | EX-101.LAB | 34240
12 | XBRL PRESENTATION FILE | aldx-20240620_pre.xml | EX-101.PRE | 22357
24 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0208142-8k_aldeyra_htm.xml | XML | 3688

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 241054030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)